Epigenetics of dementia: understanding the disease as a transformation rather than a state

2016, 2016 Alzheimer's disease facts and figures, Alzheimers Dement, 12, 459, 10.1016/j.jalz.2016.03.001 Erkinjuntti, 2009, The concept of vascular cognitive impairment, Front Neurol Neurosci, 24, 79, 10.1159/000197886 Hottman, 2014, HDL and cognition in neurodegenerative disorders, Neurobiol Dis, 72, 22, 10.1016/j.nbd.2014.07.015 Vann Jones, 2014, The prevalence and incidence of dementia with Lewy bodies: a systematic review of population and clinical studies, Psychol Med, 44, 673, 10.1017/S0033291713000494 McCann, 2014, Alpha-synucleinopathy phenotypes, Parkinsonism Relat Disord, 20, S62, 10.1016/S1353-8020(13)70017-8 Neumann, 2006, Ubiquitinated TDP43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis, Science, 314, 130, 10.1126/science.1134108 Onyike, 2013, The epidemiology of frontotemporal dementia, Int Rev Psychiatry, 25, 130, 10.3109/09540261.2013.776523 Wagner, 2015, State and metropolitan area-based amyotrophic lateral sclerosis (ALS) surveillance, Amyotroph Lateral Scler Frontotemporal Degener, 17, 1 Knopman, 2011, Estimating the number of persons with frontotemporal lobar degeneration in the US population, J Mol Neurosci, 45, 330, 10.1007/s12031-011-9538-y Brenowitz, 2014, Hippocampal sclerosis of aging is a key Alzheimer's disease mimic: clinical-pathologic correlations and comparisons with both Alzheimer's disease and non-tauopathic frontotemporal lobar degeneration, J Alzheimers Dis, 39, 691, 10.3233/JAD-131880 Kawas, 2015, Multiple pathologies are common and related to dementia in the oldest-old: the 90+ Study, Neurology, 85, 535, 10.1212/WNL.0000000000001831 Crary, 2014, Primary age-related tauopathy (PART): a common pathology associated with human aging, Acta Neuropathol, 128, 755, 10.1007/s00401-014-1349-0 Attems, 2014, Quantitative neuropathological assessment to investigate cerebral multi-morbidity, Alzheimers Res Ther, 6, 85, 10.1186/s13195-014-0085-y Prince, 2013, The global prevalence of dementia: a systematic review and metaanalysis, Alzheimers Dement, 9, 63, 10.1016/j.jalz.2012.11.007 Maloney, 2012, Applying epigenetics to Alzheimer's disease via the latent early-life associated regulation (LEARn) model, Curr Alzheimer Res, 9, 589, 10.2174/156720512800617955 Van Cauwenberghe, 2015, The genetic landscape of Alzheimer disease: clinical implications and perspectives, Genet Med Cruts T Cuenco, 2008, Association of distinct variants in SORL1 with cerebrovascular and neurodegenerative changes related to Alzheimer disease, Arch Neurol, 65, 1640, 10.1001/archneur.65.12.1640 Melville, 2012, Multiple loci influencing hippocampal degeneration identified by genome scan, Ann Neurol, 72, 65, 10.1002/ana.23644 Lill, 2012, Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: the PDGene database, PLoS Genet, 8, e1002548, 10.1371/journal.pgen.1002548 Nalls, 2014, Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease, Nat Genet, 46, 989, 10.1038/ng.3043 Lill, 2011, Keeping up with genetic discoveries in amyotrophic lateral sclerosis: the ALSoD and ALSGene databases, Amyotroph Lateral Scler, 12, 238, 10.3109/17482968.2011.584629 Bertram, 2007, Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database, Nat Genet, 39, 17, 10.1038/ng1934 Bertram, 2007, Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database, Nat Genet, 39, 17, 10.1038/ng1934 Schmidt, 2012, Genetics of subcortical vascular dementia, Exp Gerontol, 47, 873, 10.1016/j.exger.2012.06.003 Ning, 2011, Genetic evidence that vascular dementia is related to Alzheimer's disease: genetic association between tau polymorphism and vascular dementia in the Chinese population, Age Ageing, 40, 125, 10.1093/ageing/afq131 Petrucci, 2016, Phenotypic spectrum of alpha-synuclein mutations: new insights from patients and cellular models, Parkinsonism Relat Disord, 22, S16, 10.1016/j.parkreldis.2015.08.015 Ohtake, 2004, Beta-synuclein gene alterations in dementia with Lewy bodies, Neurology, 63, 805, 10.1212/01.WNL.0000139870.14385.3C Gorostidi, 2012, Alpha-synuclein levels in blood plasma from LRRK2 mutation carriers, PLoS One, 7, e52312, 10.1371/journal.pone.0052312 Hall, 2006, Cholesterol, APOE genotype, and Alzheimer disease: an epidemiologic study of Nigerian Yoruba, Neurology, 66, 223, 10.1212/01.wnl.0000194507.39504.17 Brickell, 2007, Clinicopathological concordance and discordance in three monozygotic twin pairs with familial Alzheimer's disease, J Neurol Neurosurg Psychiatry, 78, 1050, 10.1136/jnnp.2006.113803 Iacono, 2014, Neuropathologic assessment of dementia markers in identical and fraternal twins, Brain Pathol, 24, 317, 10.1111/bpa.12127 Chouliaras, 2013, Consistent decrease in global DNA methylation and hydroxymethylation in the hippocampus of Alzheimer's disease patients, Neurobiol Aging, 34, 2091, 10.1016/j.neurobiolaging.2013.02.021 Ketelaar, 2012, What monozygotic twins discordant for phenotype illustrate about mechanisms influencing genetic forms of neurodegeneration, Clin Genet, 81, 325, 10.1111/j.1399-0004.2011.01795.x Mastroeni, 2009, Epigenetic differences in cortical neurons from a pair of monozygotic twins discordant for Alzheimer's disease, PLoS One, 4, e6617, 10.1371/journal.pone.0006617 Woodard, 2014, iPSC-derived dopamine neurons reveal differences between monozygotic twins discordant for Parkinson's disease, Cell Rep, 9, 1173, 10.1016/j.celrep.2014.10.023 Wang, 2009, Twin pairs discordant for neuropathologically confirmed Lewy body dementia, J Neurol Neurosurg Psychiatry, 80, 562, 10.1136/jnnp.2008.151654 Meltz Steinberg, 2015, Whole genome analyses reveal no pathogenetic single nucleotide or structural differences between monozygotic twins discordant for amyotrophic lateral sclerosis, Amyotroph Lateral Scler Frontotemporal Degener, 16, 1, 10.3109/21678421.2015.1040029 Yip, 2005, Nonsteroidal anti-inflammatory drug use and Alzheimer's disease risk: the MIRAGE Study, BMC Geriatr, 5, 2, 10.1186/1471-2318-5-2 Perneczky, 2009, Education attenuates the effect of medial temporal lobe atrophy on cognitive function in Alzheimer's disease: the MIRAGE study, J Alzheimers Dis, 17, 855, 10.3233/JAD-2009-1117 Yang, 2015, Accumulation of amyloid in cognitive impairment after mild traumatic brain injury, J Neurol Sci, 349, 99, 10.1016/j.jns.2014.12.032 Rockenstein, 2014, Accumulation of oligomer-prone alpha-synuclein exacerbates synaptic and neuronal degeneration in vivo, Brain, 137, 1496, 10.1093/brain/awu057 Mattsson, 2014, Emerging beta-amyloid pathology and accelerated cortical atrophy, JAMA Neurol, 71, 725, 10.1001/jamaneurol.2014.446 Lee, 2012, Tau and tauopathies, Prog Mol Biol Transl Sci, 107, 263, 10.1016/B978-0-12-385883-2.00004-7 Hamidi, 2015, Genetic alterations of DNA methylation machinery in human diseases, Epigenomics, 7, 247, 10.2217/epi.14.80 Kouzarides, 2007, Chromatin modifications and their function, Cell, 128, 693, 10.1016/j.cell.2007.02.005 Al-Mahdawi, 2014, The emerging role of 5-hydroxymethylcytosine in neurodegenerative diseases, Front Neurosci, 8, 397, 10.3389/fnins.2014.00397 Zawia, 2009, Epigenetics, oxidative stress, and Alzheimer disease, Free Radic Biol Med, 46, 1241, 10.1016/j.freeradbiomed.2009.02.006 Hendrickx, 2014, Epigenetic regulations of immediate early genes expression involved in memory formation by the amyloid precursor protein of Alzheimer disease, PLoS One, 9, e99467, 10.1371/journal.pone.0099467 Wang, 2014, Epigenetic suppression of hippocampal BDNF mediates the memory deficiency induced by amyloid fibrils, Pharmacol Biochem Behav, 126, 83, 10.1016/j.pbb.2014.09.009 Noh, 2014, Age-dependent effects of valproic acid in Alzheimer's disease (AD) mice are associated with nerve growth factor (NGF) regulation, Neuroscience, 266, 255, 10.1016/j.neuroscience.2014.02.012 Yasui, 2007, Integrated epigenomic analyses of neuronal MeCP2 reveal a role for long-range interaction with active genes, Proc Natl Acad Sci USA, 104, 19416, 10.1073/pnas.0707442104 Zelko, 2010, CpG methylation attenuates Sp1 and Sp3 binding to the human extracellular superoxide dismutase promoter and regulates its cell-specific expression, Free Radic Biol Med, 48, 895, 10.1016/j.freeradbiomed.2010.01.007 Dosunmu, 2009, Lifespan profiles of Alzheimer's disease-associated genes and products in monkeys and mice, J Alzheimers Dis, 18, 211, 10.3233/JAD-2009-1138 Cohen, 2011, Genome-wide activity-dependent MeCP2 phosphorylation regulates nervous system development and function, Neuron, 72, 72, 10.1016/j.neuron.2011.08.022 Valinluck, 2004, Oxidative damage to methyl-CpG sequences inhibits the binding of the methyl-CpG binding domain (MBD) of methyl-CpG binding protein 2 (MeCP2), Nucleic Acids Res, 32, 4100, 10.1093/nar/gkh739 Jacob, 2013, Alzheimer's disease-associated polymorphisms in human OGG1 alter catalytic activity and sensitize cells to DNA damage, Free Radic Biol Med, 63, 115, 10.1016/j.freeradbiomed.2013.05.010 Rusiecki, 2008, Global DNA hypomethylation is associated with high serum-persistent organic pollutants in Greenlandic Inuit, Environ Health Perspect, 116, 1547, 10.1289/ehp.11338 Kim, 2010, Association of low-dose exposure to persistent organic pollutants with global DNA hypomethylation in healthy Koreans, Environ Health Perspect, 118, 370, 10.1289/ehp.0901131 Zhao, 2014, Up-regulation of microRNA-210 induces immune dysfunction via targeting FOXP3 in CD4(+) T cells of psoriasis vulgaris, Clin Immunol, 150, 22, 10.1016/j.clim.2013.10.009 Shaw, 2001, Phenserine regulates translation of beta-amyloid precursor protein mRNA by a putative interleukin-1 responsive element, a target for drug development, Proc Natl Acad Sci U S A, 98, 7605, 10.1073/pnas.131152998 Long, 2014, MicroRNA-339-5p down-regulates protein expression of beta-site amyloid precursor protein-cleaving enzyme 1 (BACE1) in human primary brain cultures and is reduced in brain tissue specimens of Alzheimer disease subjects, J Biol Chem, 289, 5184, 10.1074/jbc.M113.518241 Evans, 2004, Cholesterol and APOE genotype interact to influence Alzheimer disease progression, Neurology, 62, 1869, 10.1212/01.WNL.0000125323.15458.3F Holtzman, 2012, Apolipoprotein E and apolipoprotein E receptors: normal biology and roles in Alzheimer disease, Cold Spring Harb Perspect Med, 2, a006312, 10.1101/cshperspect.a006312 Verghese, 2013, ApoE influences amyloid-beta (Abeta) clearance despite minimal apoE/Abeta association in physiological conditions, Proc Natl Acad Sci USA, 110, E1807, 10.1073/pnas.1220484110 Rasmussen, 2015, Plasma levels of apolipoprotein E and risk of dementia in the general population, Ann Neurol, 77, 301, 10.1002/ana.24326 Yu, 2013, Epigenetic signature and enhancer activity of the human APOE gene, Hum Mol Genet, 22, 5036, 10.1093/hmg/ddt354 Tartaglione, 2015, Early-life toxic insults and onset of sporadic neurodegenerative diseases—an overview of experimental studies, Curr Top Behav Neurosci, 10.1007/7854_2015_416 Bekkering, 2015, The epigenetic memory of monocytes and macrophages as a novel drug target in atherosclerosis, Clin Ther, 37, 914, 10.1016/j.clinthera.2015.01.008 Brown, 2014, Poised epigenetic states and acquired drug resistance in cancer, Nat Rev Cancer, 14, 747, 10.1038/nrc3819 Zager, 2013, ‘Biologic memory’ in response to acute kidney injury: cytoresistance, toll-like receptor hyper-responsiveness and the onset of progressive renal disease, Nephrol Dial Transplant, 28, 1985, 10.1093/ndt/gft101 Comer, 2015, Epigenetic targets for novel therapies of lung diseases, Pharmacol Ther, 147, 91, 10.1016/j.pharmthera.2014.11.006 Montalvo-Ortiz, 2014, HDAC inhibitors restore the capacity of aged mice to respond to haloperidol through modulation of histone acetylation, Neuropsychopharmacology, 39, 1469, 10.1038/npp.2013.346 Hardy, 2009, The amyloid hypothesis for Alzheimer's disease: a critical reappraisal, J Neurochem, 110, 1129, 10.1111/j.1471-4159.2009.06181.x Nabuurs, 2013, MR microscopy of human amyloid-beta deposits: characterization of parenchymal amyloid, diffuse plaques, and vascular amyloid, J Alzheimers Dis, 34, 1037, 10.3233/JAD-122215 Snyder, 2015, Vascular contributions to cognitive impairment and dementia including Alzheimer's disease, Alzheimers Dement, 11, 710, 10.1016/j.jalz.2014.10.008 Kast, 2014, Sequestration of latent TGF-beta binding protein 1 into CADASIL-related Notch3-ECD deposits, Acta Neuropathol Comm, 2, 96, 10.1186/s40478-014-0096-8 Bodles, 2004, Alpha-synuclein aggregation, Protein Peptide Lett, 11, 271, 10.2174/0929866043407084 Delacourte, 2005, Tauopathies: recent insights into old diseases, Folia Neuropathol, 43, 244 Lalmansingh, 2011, TDP-43 is a transcriptional repressor: the testis-specific mouse acrv1 gene is a TDP-43 target in vivo, J Biol Chem, 286, 10970, 10.1074/jbc.M110.166587 Arai, 2009, Phosphorylated TDP-43 in Alzheimer's disease and dementia with Lewy bodies, Acta Neuropathol, 117, 125, 10.1007/s00401-008-0480-1 Nelson, 2013, Hippocampal sclerosis of aging, a prevalent and high-morbidity brain disease, Acta Neuropathol, 126, 161, 10.1007/s00401-013-1154-1 Gavett, 2011, Chronic traumatic encephalopathy: a potential late effect of sport-related concussive and subconcussive head trauma, Clin Sports Med, 30, 179, 10.1016/j.csm.2010.09.007 Tian, 2011, TDP-43 potentiates alpha-synuclein toxicity to dopaminergic neurons in transgenic mice, Int J Biol Sci, 7, 234, 10.7150/ijbs.7.234 Nakashima-Yasuda, 2007, Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases, Acta Neuropathol, 114, 221, 10.1007/s00401-007-0261-2 Chauhan, 1991, Action of amyloid beta-protein on protein kinase C activity, Life Sci, 49, 1555, 10.1016/0024-3205(91)90328-9 Kontopoulos, 2006, Alpha-synuclein acts in the nucleus to inhibit histone acetylation and promote neurotoxicity, Hum Mol Genet, 15, 3012, 10.1093/hmg/ddl243 Ding, 2008, Histone deacetylase 6 interacts with the microtubule-associated protein tau, J Neurochem, 106, 2119, 10.1111/j.1471-4159.2008.05564.x Fiesel, 2010, Knockdown of transactive response DNA-binding protein (TDP-43) downregulates histone deacetylase 6, EMBO J, 29, 209, 10.1038/emboj.2009.324 Dubois, 2014, Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria, Lancet Neurol, 13, 614, 10.1016/S1474-4422(14)70090-0 Migliore, 2009, Genetics, environmental factors and the emerging role of epigenetics in neurodegenerative diseases, Mutat Res, 667, 82, 10.1016/j.mrfmmm.2008.10.011 Lee, 2014, The neuropathology of obesity: insights from human disease, Acta Neuropathol, 127, 3, 10.1007/s00401-013-1190-x Vanitallie, 2013, Preclinical sporadic Alzheimer's disease: target for personalized diagnosis and preventive intervention, Metabolism, 62, S30, 10.1016/j.metabol.2012.08.024 Morris, 2014, Dietary fat composition and dementia risk, Neurobiol Aging, 35, S59, 10.1016/j.neurobiolaging.2014.03.038 Treiber, 2011, Cognitive stimulation and cognitive and functional decline in Alzheimer's disease: the cache county dementia progression study, J Gerontol B Psychol Sci Soc Sci, 66, 416, 10.1093/geronb/gbr023 Okonkwo, 2014, Physical activity attenuates age-related biomarker alterations in preclinical AD, Neurology, 83, 1753, 10.1212/WNL.0000000000000964 Tian, 2015, Objective measures of physical activity, white matter integrity and cognitive status in adults over age 80, Behav Brain Res, 284, 51, 10.1016/j.bbr.2015.01.045 Cohen, 2006, Opposing activities protect against age-onset proteotoxicity, Science, 313, 1604, 10.1126/science.1124646 Song, 2010, Environmental neurotoxic pesticide increases histone acetylation to promote apoptosis in dopaminergic neuronal cells: relevance to epigenetic mechanisms of neurodegeneration, Mol Pharmacol, 77, 621, 10.1124/mol.109.062174 Baltazar, 2014, Pesticides exposure as etiological factors of Parkinson's disease and other neurodegenerative diseases—a mechanistic approach, Toxicol Lett, 230, 85, 10.1016/j.toxlet.2014.01.039 Lin, 2015, Increased risk of dementia in patients with acute organophosphate and carbamate poisoning: a nationwide population-based cohort study, Medicine (Baltimore), 94, e1187, 10.1097/MD.0000000000001187 Klimentidis, 2011, Canaries in the coal mine: a cross-species analysis of the plurality of obesity epidemics, Proc Biol Sci, 278, 1626, 10.1098/rspb.2010.1890 Condliffe, 2014, Cross-region reduction in 5-hydroxymethylcytosine in Alzheimer's disease brain, Neurobiol Aging, 35, 1850, 10.1016/j.neurobiolaging.2014.02.002 De Jager, 2014, Alzheimer's disease: early alterations in brain DNA methylation at ANK1, BIN1, RHBDF2 and other loci, Nat Neurosci, 17, 1156, 10.1038/nn.3786 Yu, 2015, Association of brain DNA methylation in SORL1, ABCA7, HLA-DRB5, SLC24A4, and BIN1 with pathological diagnosis of Alzheimer disease, JAMA Neurol, 72, 15, 10.1001/jamaneurol.2014.3049 Sanchez-Mut, 2014, Promoter hypermethylation of the phosphatase DUSP22 mediates PKA-dependent TAU phosphorylation and CREB activation in Alzheimer's disease, Hippocampus, 24, 363, 10.1002/hipo.22245 Belzil, 2014, Characterization of DNA hypermethylation in the cerebellum of c9FTD/ALS patients, Brain Res, 1584, 15, 10.1016/j.brainres.2014.02.015 Belzil, 2013, Reduced C9orf72 gene expression in c9FTD/ALS is caused by histone trimethylation, an epigenetic event detectable in blood, Acta Neuropathol, 126, 895, 10.1007/s00401-013-1199-1 Wirdefeldt, 2004, No evidence for heritability of Parkinson disease in Swedish twins, Neurology, 63, 305, 10.1212/01.WNL.0000129841.30587.9D Zhang, 2013, The role of HDAC6 in Alzheimer's disease, J Alzheimers Dis, 33, 283, 10.3233/JAD-2012-120727 Jowaed, 2010, Methylation regulates alpha-synuclein expression and is decreased in Parkinson's disease patients' brains, J Neurosci, 30, 6355, 10.1523/JNEUROSCI.6119-09.2010 Du, 2014, Histone deacetylase 6 regulates cytotoxic alpha-synuclein accumulation through induction of the heat shock response, Neurobiol Aging, 35, 2316, 10.1016/j.neurobiolaging.2014.04.029 Coupland, 2014, DNA methylation of the MAPT gene in Parkinson's disease cohorts and modulation by vitamin E in vitro, Mov Disord, 29, 1606, 10.1002/mds.25784 Kikuchi, 2011, Urinary 8-OHdG elevations in a partial lesion rat model of Parkinson's disease correlate with behavioral symptoms and nigrostriatal dopaminergic depletion, J Cell Physiol, 226, 1390, 10.1002/jcp.22467 Desai, 2015, Epigenomics, gestational programming and risk of metabolic syndrome, Int J Obes (Lond), 39, 633, 10.1038/ijo.2015.13 Panza, 2010, Metabolic syndrome and cognitive impairment: current epidemiology and possible underlying mechanisms, J Alzheimers Dis, 21, 691, 10.3233/JAD-2010-091669 Van den Hove, 2014, Epigenetically regulated microRNAs in Alzheimer's disease, Neurobiol Aging, 35, 731, 10.1016/j.neurobiolaging.2013.10.082 Hodgson, 2013, Soluble oligomers of amyloid-beta cause changes in redox state, DNA methylation, and gene transcription by inhibiting EAAT3 mediated cysteine uptake, J Alzheimers Dis, 36, 197, 10.3233/JAD-130101 Dominissini, 2014, Genomics and proteomics. Roadmap to the epitranscriptome, Science, 346, 1192, 10.1126/science.aaa1807 Sandve, 2011, The differential disease regulome, BMC Genomics, 12, 353, 10.1186/1471-2164-12-353 Krebs, 2016 Nonne, 2010, Tandem affinity purification of miRNA target mRNAs (TAP-Tar), Nucleic Acids Res, 38, e20, 10.1093/nar/gkp1100 Baek, 2008, The impact of microRNAs on protein output, Nature, 455, 64, 10.1038/nature07242 Aavik, 2015, Global DNA methylation analysis of human atherosclerotic plaques reveals extensive genomic hypomethylation and reactivation at imprinted locus 14q32 involving induction of a miRNA cluster, Eur Heart J, 36, 993, 10.1093/eurheartj/ehu437 Xie, 2011, Comprehensive microRNA analysis in bleomycin-induced pulmonary fibrosis identifies multiple sites of molecular regulation, Physiol Genomics, 43, 479, 10.1152/physiolgenomics.00222.2010 Spencer, 2012, Unraveling 50-year-old clues linking neurodegeneration and cancer to cycad toxins: are micrornas common mediators?, Front Genet, 3, 192, 10.3389/fgene.2012.00192 Piaceri, 2015, Epigenetic modifications in Alzheimer's disease: cause or effect?, J Alzheimers Dis, 43, 1169, 10.3233/JAD-141452 Dias, 2014, Parental olfactory experience influences behavior and neural structure in subsequent generations, Nat Neurosci, 17, 89, 10.1038/nn.3594 Reis, 2012, More epigenetic hits than meets the eye: microRNAs and genes associated with the tumorigenesis of retinoblastoma, Front Genet, 3, 284, 10.3389/fgene.2012.00284 Bihaqi, 2012, Do epigenetic pathways initiate late onset Alzheimer disease (LOAD): towards a new paradigm, Curr Alzheimer Res, 9, 574, 10.2174/156720512800617982 Zarin, 2015, The proposed rule for U.S. clinical trial registration and results submission, N Engl J Med, 372, 174, 10.1056/NEJMsr1414226 Lahiri, 2013, Autism as early neurodevelopmental disorder: evidence for an sAPPalpha-mediated anabolic pathway, Front Cell Neurosci, 7, 94, 10.3389/fncel.2013.00094 Caraci, 2013, Epigenetic drugs for Alzheimer's disease: hopes and challenges, Br J Clin Pharmacol, 75, 1154, 10.1111/j.1365-2125.2012.04443.x Baierle, 2014, Fatty acid status and its relationship to cognitive decline and homocysteine levels in the elderly, Nutrients, 6, 3624, 10.3390/nu6093624 Huang, 2011, High consumption of Ω-3 polyunsaturated fatty acids decrease plasma homocysteine: a meta-analysis of randomized, placebo-controlled trials, Nutrition, 27, 863, 10.1016/j.nut.2010.12.011 Ray, 2011, Neuroprotective and neurorescue effects of a novel polymeric nanoparticle formulation of curcumin (NanoCurc) in the neuronal cell culture and animal model: implications for Alzheimer's disease, J Alzheimers Dis, 23, 61, 10.3233/JAD-2010-101374 Gupta, 2013, Therapeutic roles of curcumin: lessons learned from clinical trials, AAPSJ, 15, 195, 10.1208/s12248-012-9432-8 Shu, 2011, Epigenetic CpG demethylation of the promoter and reactivation of the expression of Neurog1 by curcumin in prostate LNCaP cells, AAPSJ, 13, 606, 10.1208/s12248-011-9300-y Smith, 2010, Effects of the dietary approaches to stop hypertension diet, exercise, and caloric restriction on neurocognition in overweight adults with high blood pressure, Hypertension, 55, 1331, 10.1161/HYPERTENSIONAHA.109.146795 Lahiri, 2014, Lessons from a BACE1 inhibitor trial: off-site but not off base, Alzheimers Dementia, 10, S411, 10.1016/j.jalz.2013.11.004 Evans, 2009, Childhood poverty, chronic stress, and adult working memory, Proc Natl Acad Sci USA, 106, 6545, 10.1073/pnas.0811910106 Dias-Ferreira, 2009, Chronic stress causes frontostriatal reorganisation and affects decision-making, Science, 325, 621, 10.1126/science.1171203 Van Vliet, 2007, Epigenetic mechanisms in the context of complex diseases, Cell Mol Life Sci, 64, 1531, 10.1007/s00018-007-6526-z Vucetic, 2011, Chronic high-fat diet drives postnatal epigenetic regulation of mu-opioid receptor in the brain, Neuropsychopharmacology, 36, 1199, 10.1038/npp.2011.4 Lahiri, 2010, The “LEARn” (latent early-life associated regulation) model integrates environmental risk factors and the developmental basis of Alzheimer's disease, and proposes remedial steps, Exp Gerontol, 45, 291, 10.1016/j.exger.2010.01.001 Chan, 2006, Supplementation with apple juice attenuates presenilin-1 overexpression during dietary and genetically-induced oxidative stress, J Alzheimers Dis, 10, 353, 10.3233/JAD-2006-10401 Chan, 2010, A vitamin/nutriceutical formulation improves memory and cognitive performance in community-dwelling adults without dementia, J Nutr Health Aging, 14, 224, 10.1007/s12603-010-0054-5 Wengreen, 2013, Prospective study of Dietary Approaches to Stop Hypertension and Mediterranean-style dietary patterns and age-related cognitive change: the Cache County Study on Memory, Health and Aging, Am J Clin Nutr, 98, 1263, 10.3945/ajcn.112.051276 Rigacci, 2015, Olive oil phenols as promising multi-targeting agents against Alzheimer's disease, Adv Exp Med Biol, 863, 1, 10.1007/978-3-319-18365-7_1 Corella, 2014, How does the Mediterranean diet promote cardiovascular health? Current progress toward molecular mechanisms: gene–diet interactions at the genomic, transcriptomic, and epigenomic levels provide novel insights into new mechanisms, Bioessays, 36, 526, 10.1002/bies.201300180 Montgomery, 2014, The effect of S-adenosylmethionine on cognitive performance in mice: an animal model meta-analysis, PLoS One, 9, e107756, 10.1371/journal.pone.0107756 Ghosh, 2010, Tissue specific DNA methylation of CpG islands in normal human adult somatic tissues distinguishes neural from non-neural tissues, Epigenetics, 5, 527, 10.4161/epi.5.6.12228 Bjornsson, 2008, Intra-individual change over time in DNA methylation with familial clustering, JAMA, 299, 2877, 10.1001/jama.299.24.2877 Nasrallah, 2010, Differential effects of antipsychotic and antidepressant drugs on neurogenic regions in rats, Brain Res, 1354, 23, 10.1016/j.brainres.2010.07.075 Marioni, 2015, DNA methylation age of blood predicts all-cause mortality in later life, Genome Biol, 16, 25, 10.1186/s13059-015-0584-6 Fraga, 2005, Epigenetic differences arise during the lifetime of monozygotic twins, Proc Natl Acad Sci USA, 102, 10604, 10.1073/pnas.0500398102 Ottini, 2015, Gene promoter methylation and DNA repair capacity in monozygotic twins with discordant smoking habits, Mutat Res Genet Toxicol Environ Mutagen, 779, 57, 10.1016/j.mrgentox.2015.01.006 Murgatroyd, 2009, Dynamic DNA methylation programs persistent adverse effects of early-life stress, Nat Neurosci, 12, 1559, 10.1038/nn.2436 Lu, 2004, Gene regulation and DNA damage in the ageing human brain, Nature, 429, 883, 10.1038/nature02661 Radak, 2001, Regular exercise improves cognitive function and decreases oxidative damage in rat brain, Neurochem Int, 38, 17, 10.1016/S0197-0186(00)00063-2 Basha, 2005, The fetal basis of amyloidogenesis: exposure to lead and latent overexpression of amyloid precursor protein and beta-amyloid in the aging brain, J Neurosci, 25, 823, 10.1523/JNEUROSCI.4335-04.2005 Wu, 2008, Alzheimer's disease (AD)-like pathology in aged monkeys after infantile exposure to environmental metal lead (Pb): evidence for a developmental origin and environmental link for AD, J Neurosci, 28, 3, 10.1523/JNEUROSCI.4405-07.2008 Lahiri, 2009, The LEARn model: an epigenetic explanation for idiopathic neurobiological diseases, Mol Psychiatry, 14, 992, 10.1038/mp.2009.82 Lahiri, 2012, Gene x environment interaction by a longitudinal epigenome-wide association study (LEWAS) overcomes limitations of genome-wide association study (GWAS), Epigenomics, 4, 685, 10.2217/epi.12.60 Jackson, 2016, What could you do with 400 years of biological history on African Americans? Evaluating the potential scientific benefit of systematic studies of dental and skeletal materials on African Americans from the 17th through 20th centuries, Am J Hum Biol, 10.1002/ajhb.22821 Vradenburg Berndt, 2016, Meta-analysis of genome-wide association studies discovers multiple loci for chronic lymphocytic leukemia, Nat Commun, 7, 10933, 10.1038/ncomms10933 Gomez-Pinilla, 2011, Exercise impacts brain-derived neurotrophic factor plasticity by engaging mechanisms of epigenetic regulation, Eur J Neurosci, 33, 383, 10.1111/j.1460-9568.2010.07508.x